Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35665495

Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer
Publication date
2022 Aug 1
First author
Desai AV

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Desai AV
      type
      Author
    2. name
      Applebaum MA
      type
      Author
    3. name
      Karrison TG
      type
      Author
    4. name
      Oppong A
      type
      Author
    5. name
      Yuan C
      type
      Author
    6. name
      Berg KR
      type
      Author
    7. name
      MacQuarrie K
      type
      Author
    8. name
      Sokol E
      type
      Author
    9. name
      Hall AG
      type
      Author
    10. name
      Pinto N
      type
      Author
    11. name
      Wolfe I
      type
      Author
    12. name
      Mody R
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Desai AV
      type
      Author
    2. name
      Applebaum MA
      type
      Author
    3. name
      Karrison TG
      type
      Author
    4. name
      Oppong A
      type
      Author
    5. name
      Yuan C
      type
      Author
    6. name
      Berg KR
      type
      Author
    7. name
      MacQuarrie K
      type
      Author
    8. name
      Sokol E
      type
      Author
    9. name
      Hall AG
      type
      Author
    10. name
      Pinto N
      type
      Author
    11. name
      Wolfe I
      type
      Author
    12. name
      Mody R
      type
      Author
    bibliography ids
    1. nci-bib-0562ba09ff7de554bab5b528
    book metadata
    content sha256
    97430422c92286e4ce8b6b29a4fdd5f83663cfd4ad0a95926e639dafa751e219
    document type
    citation
    dois
    1. 10.1002/cncr.34263
    electronic publication date
    display
    2022 Jun 6
    precision
    day
    year
    2022
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:35665495
    immutable id
    pubmed:35665495@97430422c92286e4ce8b6b29a4fdd5f83663cfd4ad0a95926e639dafa751e219
    journal
    abbreviation
    Cancer
    issn electronic
    1097-0142
    issn print
    0008-543X
    issue
    15
    name
    Cancer
    nlm unique id
    0374236
    pages
    2967-2977
    volume
    128
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      35665495
      provenance
      batch id
      9d150d55960e0c12aada
      provider
      NCBI PubMed ESummary
      record sha256
      1f9df332dee2ebac0febcd246e166b1c476a7f7e71b955b749a8f9fb3e0fef5a
      response sha256
      2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
      retrieved at
      2026-09-09T23:48:09.820498+00:00
      publication date
      display
      2022 Aug 1
      precision
      day
      year
      2022
      publication types
      1. Journal Article
      2. Multicenter Study
      3. Research Support, Non-U.S. Gov't
      4. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/35665495/
      title
      Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.

      Preserved source evidence · Not medical advice